ÜberblickChartNachrichtenTraderScreen

Turning Point Therapeutics/  US90041T1088  /

IEX
16.08.2022  22:02:15 Diff. - Volumen Geld- Brief- Tageshoch Tagestief
76,01USD - 40.519
Umsatz: 3,08 Mio.		 -Geld Vol: - -Brief Vol: - 76,01 75,99
TeleTrader 09:37 China: Russia, Ukraine must both recognize peace conference
GlobeNewswire 09:30 XTCC partners with Circulariti to support sustainability and carbon neutrality in the end to end fa...
GlobeNewswire 09:15 HSBC Continental Europe: Post Stabilisation Notice
Newsfile Corp 09:06 me88 Launches me scoreAI: Revolutionizing Football Predictions for UEFA Euro Cup 2024
Newsfile Corp 09:01 ReGen III Announces Closing of Initial Tranche of Convertible Debenture Offering
TeleTrader 09:00 Europe opens mixed ahead of CPI data
GlobeNewswire 09:00 insightsoftware to Strengthen xP&A and Write-Back Capabilities in Qlik With Fiplana Acquisition
TeleTrader 08:57 China says not providing arms to any side in Ukraine conflict
TeleTrader 08:48 French inflation unchanged at 2.2% in May
TeleTrader 08:44 NATO chief: Kremlin escalation threat not new
TeleTrader 08:30 Swiss retail sales up 2.7% in April
GlobeNewswire 08:14 STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire 08:09 DePIN Mining Aggregator ‘Hivello’ Launches Private Beta Application
TeleTrader 08:00 Annual UK house prices up 1.3% in May
TeleTrader 08:00 German retail sales down 0.6% in April
GlobeNewswire 08:00 Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
TeleTrader 07:55 Europe higher premarket ahead of economic data
GlobeNewswire 07:54 Flash News: OKX Wallet Now Integrated with DIN
TeleTrader 07:50 OPEC+ reportedly seen extending cuts further
TeleTrader 07:41 Russian forces strengthen position in Donesk
GlobeNewswire 07:30 Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
TeleTrader 07:19 Asia-Pacific mostly higher after China, Japan data
GlobeNewswire 07:05 Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire 07:05 Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire 07:00 Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...